Frazier Life Sciences Management L.P. Grows Stock Holdings i

Frazier Life Sciences Management L.P. lifted its stake in Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM – Free Report) by 0.4% in the fourth quarter, HoldingsChannel reports. The institutional investor owned 6,495,392 shares of the company’s stock after buying an additional 25,000 shares during the quarter. Mirum Pharmaceuticals makes up about 10.3% of Frazier Life Sciences Management L.P.’s […]

Related Keywords

United States , China , Stifel Nicolaus , Eric Bjerkholt , Saira Ramasastry , News Ratings For Mirum Pharmaceuticals Daily , Wetzel Investment Advisors Inc , Quest Partners , Nasdaq , China Universal Asset Management Co , Stepstone Group , Insider Transactions At Mirum Pharmaceuticals , Quarter For Mirum Pharmaceuticals , Morgan Stanley , Mirum Pharmaceuticals Stock Down , Mirum Pharmaceuticals , Cantor Fitzgerald , Exchange Commission , Frazier Life Sciences Management , Mirum Pharmaceuticals Profile , Citigroup , Mirum Pharmaceuticals Inc , Free Report , Investment Advisors , Stone Group , Universal Asset Management , Director Saira Ramasastry , Pharmaceuticals Stock Down , Get Free Report , Visit Holdingschannel , Mirum Pharmaceuticals Daily ,